1
00:00:10,768 --> 00:00:14,061
I moved to Boston
10 years ago from Chicago,

2
00:00:14,085 --> 00:00:16,680
with an interest in cancer
and in chemistry.

3
00:00:17,173 --> 00:00:20,468
You might know that chemistry
is the science of making molecules

4
00:00:20,492 --> 00:00:21,808
or, to my taste,

5
00:00:21,832 --> 00:00:23,463
new drugs for cancer.

6
00:00:23,779 --> 00:00:26,576
And you might also know that,
for science and medicine,

7
00:00:26,600 --> 00:00:29,008
Boston is a bit of a candy store.

8
00:00:30,607 --> 00:00:35,230
You can't roll a stop sign in Cambridge
without hitting a graduate student.

9
00:00:35,254 --> 00:00:37,429
The bar is called the Miracle of Science.

10
00:00:37,833 --> 00:00:40,695
The billboards say "Lab Space Available."

11
00:00:40,896 --> 00:00:43,055
And it's fair to say
that in these 10 years,

12
00:00:43,079 --> 00:00:47,386
we've witnessed absolutely the start
of a scientific revolution --

13
00:00:47,410 --> 00:00:48,889
that of genome medicine.

14
00:00:49,575 --> 00:00:52,305
We know more about the patients
that enter our clinic now

15
00:00:52,329 --> 00:00:53,488
than ever before.

16
00:00:53,512 --> 00:00:55,736
And we're able, finally,
to answer the question

17
00:00:55,760 --> 00:00:58,124
that's been so pressing for so many years:

18
00:00:58,148 --> 00:01:00,104
Why do I have cancer?

19
00:01:01,215 --> 00:01:03,336
This information
is also pretty staggering.

20
00:01:03,755 --> 00:01:06,848
You might know that, so far,
in just the dawn of this revolution,

21
00:01:06,872 --> 00:01:10,598
we know that there are perhaps
40,000 unique mutations

22
00:01:10,622 --> 00:01:13,233
affecting more than 10,000 genes,

23
00:01:13,257 --> 00:01:16,620
and that there are 500 of these genes
that are bona-fide drivers,

24
00:01:16,644 --> 00:01:18,540
causes of cancer.

25
00:01:19,634 --> 00:01:20,829
Yet comparatively,

26
00:01:20,853 --> 00:01:23,615
we have about a dozen
targeted medications.

27
00:01:24,512 --> 00:01:26,774
And this inadequacy of cancer medicine

28
00:01:26,798 --> 00:01:30,908
really hit home when my father
was diagnosed with pancreatic cancer.

29
00:01:32,750 --> 00:01:34,411
We didn't fly him to Boston.

30
00:01:34,435 --> 00:01:35,966
We didn't sequence his genome.

31
00:01:36,347 --> 00:01:39,489
It's been known for decades
what causes this malignancy.

32
00:01:40,903 --> 00:01:44,950
It's three proteins: ras, myc, p53.

33
00:01:46,377 --> 00:01:49,075
This is old information
we've known since about the 80s,

34
00:01:49,099 --> 00:01:51,019
yet there's no medicine I can prescribe

35
00:01:51,043 --> 00:01:54,606
to a patient with this
or any of the numerous solid tumors

36
00:01:54,630 --> 00:01:56,322
caused by these three ...

37
00:01:57,281 --> 00:01:59,590
Horsemen of the Apocalypse that is cancer.

38
00:01:59,979 --> 00:02:02,415
There's no ras, no myc, no p53 drug.

39
00:02:02,796 --> 00:02:05,050
And you might fairly ask: Why is that?

40
00:02:05,749 --> 00:02:08,582
And the very unsatisfying
yet scientific answer is:

41
00:02:08,606 --> 00:02:09,764
it's too hard.

42
00:02:10,320 --> 00:02:11,590
That for whatever reason,

43
00:02:11,614 --> 00:02:15,107
these three proteins have entered
a space, in the language of our field,

44
00:02:15,131 --> 00:02:17,331
that's called the undruggable genome --

45
00:02:17,355 --> 00:02:19,645
which is like calling
a computer unsurfable

46
00:02:19,669 --> 00:02:20,925
or the Moon unwalkable.

47
00:02:20,949 --> 00:02:23,057
It's a horrible term of trade.

48
00:02:23,081 --> 00:02:24,239
But what it means

49
00:02:24,263 --> 00:02:27,485
is that we've failed to identify
a greasy pocket in these proteins,

50
00:02:27,509 --> 00:02:29,779
into which we, like molecular locksmiths,

51
00:02:29,803 --> 00:02:34,895
can fashion an active, small,
organic molecule or drug substance.

52
00:02:35,474 --> 00:02:37,907
Now, as I was training
in clinical medicine

53
00:02:37,931 --> 00:02:41,392
and hematology and oncology
and stem-cell transplantation,

54
00:02:41,416 --> 00:02:43,289
what we had instead,

55
00:02:43,813 --> 00:02:48,696
cascading through the regulatory
network at the FDA,

56
00:02:48,752 --> 00:02:50,185
were these substances:

57
00:02:50,209 --> 00:02:51,518
arsenic,

58
00:02:51,542 --> 00:02:52,707
thalidomide,

59
00:02:52,731 --> 00:02:56,088
and this chemical derivative
of nitrogen mustard gas.

60
00:02:56,112 --> 00:02:58,721
And this is the 21st century.

61
00:02:59,245 --> 00:03:00,491
And so, I guess you'd say,

62
00:03:00,515 --> 00:03:03,652
dissatisfied with the performance
and quality of these medicines,

63
00:03:03,676 --> 00:03:05,949
I went back to school, in chemistry,

64
00:03:07,549 --> 00:03:12,898
with the idea that perhaps by learning
the trade of discovery chemistry

65
00:03:12,932 --> 00:03:15,805
and approaching it in the context
of this brave new world

66
00:03:15,829 --> 00:03:18,041
of the open source,

67
00:03:18,065 --> 00:03:19,493
the crowd source,

68
00:03:19,517 --> 00:03:22,822
the collaborative network
that we have access to within academia,

69
00:03:22,846 --> 00:03:27,124
that we might more quickly bring
powerful and targeted therapies

70
00:03:27,148 --> 00:03:28,510
to our patients.

71
00:03:28,891 --> 00:03:31,991
And so, please consider
this a work in progress,

72
00:03:32,015 --> 00:03:34,032
but I'd like to tell you today a story

73
00:03:34,056 --> 00:03:37,257
about a very rare cancer
called midline carcinoma,

74
00:03:38,059 --> 00:03:42,273
about the undruggable protein target
that causes this cancer,

75
00:03:42,297 --> 00:03:43,825
called BRD4,

76
00:03:44,149 --> 00:03:47,994
and about a molecule developed at my lab
at Dana-Farber Cancer Institute,

77
00:03:48,018 --> 00:03:49,170
called JQ1,

78
00:03:49,194 --> 00:03:51,416
which we affectionately named for Jun Qi,

79
00:03:51,440 --> 00:03:53,479
the chemist that made this molecule.

80
00:03:54,409 --> 00:03:57,105
Now, BRD4 is an interesting protein.

81
00:03:57,129 --> 00:04:00,810
You might ask: with all the things
cancer's trying to do to kill our patient,

82
00:04:00,834 --> 00:04:02,422
how does it remember it's cancer?

83
00:04:02,446 --> 00:04:03,877
When it winds up its genome,

84
00:04:03,901 --> 00:04:06,272
divides into two cells and unwinds again,

85
00:04:06,296 --> 00:04:08,533
why does it not turn
into an eye, into a liver,

86
00:04:08,557 --> 00:04:10,938
as it has all the genes
necessary to do this?

87
00:04:10,962 --> 00:04:12,524
It remembers that it's cancer.

88
00:04:13,388 --> 00:04:16,476
And the reason is that cancer,
like every cell in the body,

89
00:04:16,500 --> 00:04:18,476
places little molecular bookmarks,

90
00:04:18,500 --> 00:04:19,878
little Post-it notes,

91
00:04:19,902 --> 00:04:22,885
that remind the cell, "I'm cancer;
I should keep growing."

92
00:04:23,500 --> 00:04:27,513
And those Post-it notes involve this
and other proteins of its class --

93
00:04:27,537 --> 00:04:28,853
so-called bromodomains.

94
00:04:29,432 --> 00:04:32,100
So we developed an idea, a rationale,

95
00:04:32,124 --> 00:04:34,273
that perhaps if we made a molecule

96
00:04:34,297 --> 00:04:36,590
that prevented
the Post-it note from sticking

97
00:04:36,614 --> 00:04:38,273
by entering into the little pocket

98
00:04:38,297 --> 00:04:40,153
at the base of this spinning protein,

99
00:04:40,177 --> 00:04:42,233
then maybe we could convince cancer cells,

100
00:04:42,257 --> 00:04:45,058
certainly those addicted
to this BRD4 protein,

101
00:04:45,082 --> 00:04:46,399
that they're not cancer.

102
00:04:47,118 --> 00:04:49,341
And so we started to work on this problem.

103
00:04:49,365 --> 00:04:51,667
We developed libraries of compounds

104
00:04:51,691 --> 00:04:54,476
and eventually arrived
at this and similar substances

105
00:04:54,500 --> 00:04:55,682
called JQ1.

106
00:04:56,277 --> 00:04:57,841
Now, not being a drug company,

107
00:04:57,865 --> 00:05:00,959
we could do certain things,
we had certain flexibilities,

108
00:05:00,983 --> 00:05:03,817
that I respect that a pharmaceutical
industry doesn't have.

109
00:05:03,841 --> 00:05:06,091
We just started mailing it to our friends.

110
00:05:06,583 --> 00:05:07,736
I have a small lab.

111
00:05:07,760 --> 00:05:11,165
We thought we'd just send it to people
and see how the molecule behaves.

112
00:05:11,189 --> 00:05:12,639
We sent it to Oxford, England,

113
00:05:12,663 --> 00:05:15,885
where a group of talented
crystallographers provided this picture,

114
00:05:15,909 --> 00:05:19,006
which helped us understand exactly
how this molecule is so potent

115
00:05:19,030 --> 00:05:20,196
for this protein target.

116
00:05:20,220 --> 00:05:23,156
It's what we call a perfect fit
of shape complementarity,

117
00:05:23,180 --> 00:05:24,330
or hand in glove.

118
00:05:25,027 --> 00:05:26,648
Now, this is a very rare cancer,

119
00:05:26,672 --> 00:05:28,476
this BRD4-addicted cancer.

120
00:05:28,901 --> 00:05:31,132
And so we worked with samples of material

121
00:05:31,156 --> 00:05:34,730
that were collected by young pathologists
at Brigham and Women's Hospital.

122
00:05:34,754 --> 00:05:37,127
And as we treated these cells
with this molecule,

123
00:05:37,151 --> 00:05:39,190
we observed something really striking.

124
00:05:39,500 --> 00:05:40,706
The cancer cells --

125
00:05:40,730 --> 00:05:42,797
small, round and rapidly dividing,

126
00:05:42,821 --> 00:05:45,174
grew these arms and extensions.

127
00:05:45,198 --> 00:05:46,562
They were changing shape.

128
00:05:47,020 --> 00:05:48,347
In effect,

129
00:05:48,371 --> 00:05:51,678
the cancer cell
was forgetting it was cancer

130
00:05:51,702 --> 00:05:53,210
and becoming a normal cell.

131
00:05:54,776 --> 00:05:56,133
This got us very excited.

132
00:05:57,541 --> 00:06:00,129
The next step would be to put
this molecule into mice.

133
00:06:00,153 --> 00:06:03,548
The only problem was there's no
mouse model of this rare cancer.

134
00:06:03,572 --> 00:06:06,295
And so at the time
we were doing this research,

135
00:06:06,319 --> 00:06:09,892
I was caring for a 29-year-old
firefighter from Connecticut

136
00:06:09,916 --> 00:06:11,798
who was very much at the end of life

137
00:06:11,822 --> 00:06:13,678
with this incurable cancer.

138
00:06:14,321 --> 00:06:17,771
This BRD4-addicted cancer
was growing throughout his left lung.

139
00:06:17,795 --> 00:06:20,960
And he had a chest tube in
that was draining little bits of debris.

140
00:06:20,984 --> 00:06:23,945
And every nursing shift,
we would throw this material out.

141
00:06:23,969 --> 00:06:25,736
And so we approached this patient

142
00:06:25,760 --> 00:06:27,772
and asked if he would collaborate with us.

143
00:06:28,415 --> 00:06:32,114
Could we take this precious
and rare cancerous material

144
00:06:32,138 --> 00:06:33,737
from this chest tube

145
00:06:33,761 --> 00:06:35,980
and drive it across town
and put it into mice

146
00:06:36,004 --> 00:06:39,645
and try to do a clinical trial
at a stage that with a prototype drug,

147
00:06:39,669 --> 00:06:41,693
well, that would be, of course, impossible

148
00:06:41,717 --> 00:06:43,550
and, rightly, illegal to do in humans.

149
00:06:43,574 --> 00:06:44,827
And he obliged us.

150
00:06:45,706 --> 00:06:49,453
At the Lurie Family Center
for Animal Imaging,

151
00:06:49,522 --> 00:06:53,137
our colleague, Andrew Kung,
grew this cancer successfully in mice

152
00:06:53,161 --> 00:06:54,851
without ever touching plastic.

153
00:06:55,175 --> 00:06:58,591
And you can see this PET scan
of a mouse -- what we call a pet PET.

154
00:06:58,615 --> 00:07:00,171
The cancer is growing

155
00:07:00,195 --> 00:07:03,100
as this red, huge mass
in the hind limb of this animal.

156
00:07:03,521 --> 00:07:05,744
And as we treat it with our compound,

157
00:07:05,768 --> 00:07:07,376
this addiction to sugar,

158
00:07:07,400 --> 00:07:08,991
this rapid growth, faded.

159
00:07:09,015 --> 00:07:11,058
And on the animal on the right,

160
00:07:11,082 --> 00:07:13,093
you see that the cancer was responding.

161
00:07:14,169 --> 00:07:16,376
We've completed, now, clinical trials

162
00:07:16,400 --> 00:07:18,376
in four mouse models of this disease.

163
00:07:18,400 --> 00:07:20,249
And every time, we see the same thing.

164
00:07:20,273 --> 00:07:22,978
The mice with this cancer
that get the drug live,

165
00:07:23,002 --> 00:07:25,298
and the ones that don't rapidly perish.

166
00:07:27,400 --> 00:07:28,829
So we started to wonder,

167
00:07:28,853 --> 00:07:30,957
what would a drug company
do at this point?

168
00:07:30,981 --> 00:07:33,030
Well, they probably
would keep this a secret

169
00:07:33,054 --> 00:07:34,939
until they turn the prototype drug

170
00:07:34,963 --> 00:07:37,107
into an active pharmaceutical substance.

171
00:07:37,663 --> 00:07:39,104
So we did just the opposite.

172
00:07:39,484 --> 00:07:42,319
We published a paper
that described this finding

173
00:07:42,343 --> 00:07:44,319
at the earliest prototype stage.

174
00:07:45,113 --> 00:07:48,021
We gave the world the chemical
identity of this molecule,

175
00:07:48,045 --> 00:07:49,942
typically a secret in our discipline.

176
00:07:49,966 --> 00:07:51,942
We told people exactly how to make it.

177
00:07:52,639 --> 00:07:54,307
We gave them our email address,

178
00:07:54,331 --> 00:07:55,982
suggesting that if they write us,

179
00:07:56,006 --> 00:07:57,608
we'll send them a free molecule.

180
00:07:57,632 --> 00:07:58,720
(Laughter)

181
00:07:58,744 --> 00:08:01,641
We basically tried to create
the most competitive environment

182
00:08:01,665 --> 00:08:02,825
for our lab as possible.

183
00:08:02,849 --> 00:08:04,791
And this was, unfortunately, successful.

184
00:08:04,815 --> 00:08:05,839
(Laughter)

185
00:08:05,863 --> 00:08:07,868
Because now, we've shared this molecule,

186
00:08:07,892 --> 00:08:10,295
just since December of last year,

187
00:08:10,319 --> 00:08:12,574
with 40 laboratories in the United States

188
00:08:12,598 --> 00:08:14,376
and 30 more in Europe --

189
00:08:14,400 --> 00:08:16,249
many of them pharmaceutical companies,

190
00:08:16,273 --> 00:08:17,868
seeking now to enter this space,

191
00:08:17,892 --> 00:08:20,941
to target this rare cancer
that, thankfully right now,

192
00:08:21,796 --> 00:08:24,409
is quite desirable
to study in that industry.

193
00:08:26,662 --> 00:08:29,731
But the science that's coming back
from all of these laboratories

194
00:08:29,755 --> 00:08:31,589
about the use of this molecule

195
00:08:31,613 --> 00:08:34,785
has provided us insights
we might not have had on our own.

196
00:08:34,809 --> 00:08:36,787
Leukemia cells treated with this compound

197
00:08:36,811 --> 00:08:39,227
turn into normal white blood cells.

198
00:08:39,876 --> 00:08:41,657
Mice with multiple myeloma,

199
00:08:41,681 --> 00:08:44,716
an incurable malignancy
of the bone marrow,

200
00:08:45,740 --> 00:08:47,717
respond dramatically

201
00:08:47,741 --> 00:08:49,456
to the treatment with this drug.

202
00:08:50,216 --> 00:08:52,192
You might know that fat has memory.

203
00:08:53,264 --> 00:08:55,240
I'll nicely demonstrate that for you.

204
00:08:55,264 --> 00:08:56,295
(Laughter)

205
00:08:56,319 --> 00:08:57,871
In fact, this molecule

206
00:08:57,895 --> 00:09:01,295
prevents this adipocyte,
this fat stem cell,

207
00:09:01,319 --> 00:09:04,188
from remembering how to make fat,

208
00:09:04,212 --> 00:09:06,580
such that mice on a high-fat diet,

209
00:09:06,604 --> 00:09:08,718
like the folks
in my hometown of Chicago --

210
00:09:08,742 --> 00:09:09,750
(Laughter)

211
00:09:09,774 --> 00:09:11,782
fail to develop fatty liver,

212
00:09:11,806 --> 00:09:13,629
which is a major medical problem.

213
00:09:14,820 --> 00:09:16,392
What this research taught us --

214
00:09:16,416 --> 00:09:18,676
not just my lab, but our institute,

215
00:09:18,700 --> 00:09:20,772
and Harvard Medical School
more generally --

216
00:09:20,796 --> 00:09:23,057
is that we have unique
resources in academia

217
00:09:23,081 --> 00:09:24,415
for drug discovery;

218
00:09:24,439 --> 00:09:27,622
that our center, which has tested
perhaps more cancer molecules

219
00:09:27,646 --> 00:09:28,803
in a scientific way

220
00:09:28,827 --> 00:09:29,978
than any other,

221
00:09:30,002 --> 00:09:31,477
never made one of its own.

222
00:09:32,445 --> 00:09:34,612
For all the reasons you see listed here,

223
00:09:34,636 --> 00:09:37,375
we think there's a great
opportunity for academic centers

224
00:09:37,399 --> 00:09:41,223
to participate in this earliest,
conceptually tricky

225
00:09:41,247 --> 00:09:43,177
and creative discipline

226
00:09:43,201 --> 00:09:44,983
of prototype drug discovery.

227
00:09:47,772 --> 00:09:48,922
So what next?

228
00:09:49,249 --> 00:09:51,629
We have this molecule,
but it's not a pill yet.

229
00:09:51,653 --> 00:09:54,247
It's not orally bioavailable.

230
00:09:54,271 --> 00:09:57,466
We need to fix it so we can
deliver it to our patients.

231
00:09:57,490 --> 00:09:59,074
And everyone in the lab,

232
00:09:59,098 --> 00:10:01,899
especially following the interaction
with these patients,

233
00:10:01,923 --> 00:10:04,248
feels quite compelled
to deliver a drug substance

234
00:10:04,272 --> 00:10:05,470
based on this molecule.

235
00:10:05,994 --> 00:10:07,405
It's here where I'd say

236
00:10:07,429 --> 00:10:09,644
that we could use your help
and your insights,

237
00:10:09,668 --> 00:10:11,530
your collaborative participation.

238
00:10:12,481 --> 00:10:16,162
Unlike a drug company,
we don't have a pipeline

239
00:10:16,186 --> 00:10:18,193
that we can deposit these molecules into.

240
00:10:18,217 --> 00:10:20,614
We don't have a team
of salespeople and marketeers

241
00:10:20,638 --> 00:10:23,349
to tell us how to position
this drug against the other.

242
00:10:23,373 --> 00:10:26,041
What we do have is the flexibility
of an academic center

243
00:10:26,065 --> 00:10:28,001
to work with competent, motivated,

244
00:10:28,041 --> 00:10:30,946
enthusiastic, hopefully well-funded people

245
00:10:30,970 --> 00:10:33,263
to carry these molecules
forward into the clinic

246
00:10:33,287 --> 00:10:36,985
while preserving our ability
to share the prototype drug worldwide.

247
00:10:38,074 --> 00:10:40,715
This molecule will soon leave our benches

248
00:10:40,739 --> 00:10:43,789
and go into a small start-up company
called Tensha Therapeutics.

249
00:10:43,813 --> 00:10:46,749
And, really, this is the fourth
of these molecules

250
00:10:46,773 --> 00:10:49,020
to kind of "graduate"
from our little pipeline

251
00:10:49,044 --> 00:10:50,498
of drug discovery,

252
00:10:50,522 --> 00:10:54,878
two of which -- a topical drug
for lymphoma of the skin

253
00:10:55,797 --> 00:10:58,908
and an oral substance for the treatment
of multiple myeloma --

254
00:10:58,932 --> 00:11:02,170
will actually come to the bedside
for the first clinical trial

255
00:11:02,194 --> 00:11:05,717
in July of this year -- for us,
a major and exciting milestone.

256
00:11:07,149 --> 00:11:09,172
I want to leave you with just two ideas.

257
00:11:09,196 --> 00:11:13,530
The first is: if anything is unique
about this research,

258
00:11:13,554 --> 00:11:15,911
it's less the science than the strategy.

259
00:11:15,935 --> 00:11:18,357
This, for us, was a social experiment --

260
00:11:18,381 --> 00:11:23,646
an experiment in "What would happen
if we were as open and honest

261
00:11:23,670 --> 00:11:26,186
at the earliest phase
of discovery chemistry research

262
00:11:26,210 --> 00:11:27,657
as we could be?"

263
00:11:27,681 --> 00:11:30,022
This string of letters and numbers

264
00:11:30,046 --> 00:11:32,061
and symbols and parentheses

265
00:11:32,085 --> 00:11:33,704
that can be texted, I suppose,

266
00:11:33,728 --> 00:11:35,155
or Twittered worldwide,

267
00:11:36,448 --> 00:11:38,950
is the chemical identity
of our pro compound.

268
00:11:38,974 --> 00:11:43,056
It's the information that we most need
from pharmaceutical companies,

269
00:11:43,080 --> 00:11:47,794
the information on how these early
prototype drugs might work.

270
00:11:48,188 --> 00:11:50,312
Yet this information is largely a secret.

271
00:11:50,982 --> 00:11:53,861
And so we seek, really, to download

272
00:11:53,885 --> 00:11:57,004
from the amazing successes
of the computer-science industry,

273
00:11:57,028 --> 00:12:01,407
two principles -- that of open source
and that of crowdsourcing --

274
00:12:01,431 --> 00:12:07,425
to quickly, responsibly accelerate
the delivery of targeted therapeutics

275
00:12:07,449 --> 00:12:08,956
to patients with cancer.

276
00:12:09,617 --> 00:12:12,736
Now, the business model
involves all of you.

277
00:12:12,760 --> 00:12:14,736
This research is funded by the public.

278
00:12:15,085 --> 00:12:16,463
It's funded by foundations.

279
00:12:16,487 --> 00:12:18,217
And one thing I've learned in Boston

280
00:12:18,241 --> 00:12:21,315
is that you people will do anything
for cancer, and I love that.

281
00:12:21,339 --> 00:12:24,236
You bike across the state,
you walk up and down the river.

282
00:12:24,260 --> 00:12:25,800
(Laughter)

283
00:12:26,390 --> 00:12:28,716
I've never seen, really, anywhere,

284
00:12:28,740 --> 00:12:31,983
this unique support for cancer research.

285
00:12:32,007 --> 00:12:33,764
And so I want to thank you

286
00:12:33,788 --> 00:12:37,085
for your participation, your collaboration

287
00:12:37,109 --> 00:12:38,270
and most of all,

288
00:12:38,294 --> 00:12:40,228
for your confidence in our ideas.

289
00:12:40,252 --> 00:12:45,753
(Applause)